Disclaimer:All content on this platform is sourced from the internet and is provided for informational purposes only. None of the content represents the views of this site, nor does it constitute investment advice. Please exercise caution when investing.

Faster global financial news!

Hong Kong-listed innovative drug stocks rose, with Ascletis Pharma up more than 8%, Cloud9 New Horizon up more than 5%, Innovent Biologics and Kelun Biotech up nearly 5%, BeiGene, Zai Lab, and Sino Biopharm up more than 4%, and Sino Biopharmaceutical and WuXi AppTec up more than 3%.

04/01/2026 18:16 UTC
Share
Complaint Report
Hong Kong-listed innovative drug stocks rose, with Ascletis Pharma up more than 8%, Cloud9 New Horizon up more than 5%, Innovent Biologics and Kelun Biotech up nearly 5%, BeiGene, Zai Lab, and Sino Biopharm up more than 4%, and Sino Biopharmaceutical and WuXi AppTec up more than 3%.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
i
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.